Home Pilots Octave Bioscience scores $30M for neurodegenerative disease offerings Pilots Octave Bioscience scores $30M for neurodegenerative disease offerings By - July 26, 2023 34 0 Facebook Twitter Pinterest WhatsApp The multiple sclerosis-focused company will use the funds to speed up the company’s commercialization efforts. RELATED ARTICLESMORE FROM AUTHOR Pilots Medtronic issues voluntary recall of MiniMed insulin pumps Pilots Hybrid primary care company Rezilient Health scores $10M Pilots Empathy Health Technologies raises $2.8M for Sober Sidekick app LEAVE A REPLY Cancel reply Please enter your comment! Please enter your name here You have entered an incorrect email address! Please enter your email address here Save my name, email, and website in this browser for the next time I comment. FOLLOW ME0FansLike0FollowersFollow0SubscribersSubscribe POPULAR ARTICLES Virtus Health enhancing IVF patient experience with AI Pilots - February 29, 2024 0 IBM, Boehringer partner on genAI, foundation models for therapeutic antibody research Pilots - November 30, 2023 0 Uwill acquires fellow college mental health startup Virtual Care Group Pilots - July 9, 2024 0 Included Health, Pear Therapeutics announce layoffs Pilots - July 27, 2022 0 Calm buys Ripple Health Group to expand mental healthcare offering Pilots - February 2, 2022 0 POPULAR CATEGORIESPilots2166Applications682Testing237Collaborations15GitHub3